• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Blepharitis

Blepharitis - 25 Studies Found

Active, not recruiting : Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
:
  • Meibomian Gland Dysfunction
  • Posterior Blepharitis

: 2011-08-02
:
  • Drug: Loteprednol/tobramycin Z

Enrolling by invitation : The Efficacy of Permethrin 5% Treatment for Demodex - Blepharitis in Comparison to Fucithalmic (Fusidic Acid 1%) and Synthomycine 5%
: Inflammation of the Eyelids
: 2017-03-28
:
  • Drug: Permethrin 5% Facial ski

Completed : Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis
:
  • Meibomian Gland Dysfunction
  • Dry Eye
  • Posterior : 2016-10-29
    :
    • Device: Blephex Lid margin exf

Completed : Treatment of Patients With Blepharitis and Facial Rosacea
:
  • Blepharitis
  • Meibomianitis
  • Dry
    : 2007-11-16
    :
    • Drug: COL-101 (doxycycline, USP) capsules

Completed : Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
: Blepharitis
: 2014-08-13
:
  • Drug: KPI-121 KPI-121 drug pro

<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.